Submerged Versus Non-Submerged Healing of Implants Subjected To Contour Augmentation

February 15, 2024 updated by: Theofilos Koutouzis, Nova Southeastern University

Submerged Versus Non-Submerged Healing of Implants Subjected to Contour Augmentation.

It is a randomized controlled trial to evaluate two surgical techniques for dental implant placement simultaneously with bone augmentation.

Study Overview

Status

Completed

Conditions

Detailed Description

Implants receiving Contour Augmentations at the time of placement are randomized into two groups, submerged and non submerged. Healing is evaluated at 4 months post op compared to the day of surgery.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Florida
      • Davie, Florida, United States, 33314
        • Nova South Eastern university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age more than 21 years - ASA I or II.
  • Patient's willingness to participate in this study.
  • Availability for 4-month follow-up.
  • Absence of active periodontal disease.
  • Single tooth replacement is needed with simultaneous contour augmentation.
  • Available pre-operative CBCT study.
  • Extraction of tooth at least 8 weeks prior to planned implant therapy.

Exclusion Criteria:

  • Pregnancy at the screening visit.
  • Smoking more than 10 cig/day.
  • Active infection at the site of surgery (teeth involved).
  • Multiple missing teeth adjacent to each other (long span edentulous area).
  • Vertical bone defect less than 2mm (intra surgical assessment)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transmucosal (Non-Submerged)
Flaps will be adapted to the healing abutments for a trans-mucosal healing up on closure
Dental implant will be placed in transmucosal manner (Healing abutment is exposed in the mouth).
Other Names:
  • Non-submerged technique
Active Comparator: Submerged
Flaps will be advanced to achieve primary wound closure.
Dental implant will be installed in submerged manner (implant is completed covered by soft tissue).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hard tissue healing around dental implants
Time Frame: 4 months
bone healing around Submerged and Non-submerged dental implants will be measured by Periodontal probe and radiographs. A Mann-Whitney U Test will be used to calculate bone healing changes. To evaluate bone healing Mean values, standard deviations and frequencies will be calculated.
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Soft tissue healing around dental implants
Time Frame: 4 months
Soft tissue healing around Submerged and Non-submerged dental implants. Fisher's exact test will be used to evaluate soft tissue healing changes through analyzing the measurements obtained by periodontal probe and radiographs.
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stavros Sofos, DDS, Nova Southeastern University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2020

Primary Completion (Actual)

February 15, 2024

Study Completion (Actual)

February 15, 2024

Study Registration Dates

First Submitted

September 6, 2020

First Submitted That Met QC Criteria

September 16, 2020

First Posted (Actual)

September 23, 2020

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 15, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2020-341

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Loss

Clinical Trials on Transmucosal Technique

3
Subscribe